Announced

Advent International to acquire a majority stake in RA Chem Pharma from Micro Labs.

Synopsis

Advent International, agreed to acquire a majority stake in RA Chem Pharma, a vertically integrated pharmaceutical company, from Micro Labs, a multi-faceted healthcare organization. Financial terms were not disclosed. “We continue to be excited about India’s pharmaceutical landscape and investing in RA Chem Pharma will further strengthen our presence in the sector. We aim to build one of the leading API platforms in India and will leverage our financial and operational resources globally to scale RA Chem Pharma both organically and inorganically,” Shweta Jalan, Advent Managing Director and Head of India.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US